Key statistics

On Friday, GlaxoSmithKline PLC (GSK:LSE) closed at 1,627.50, -6.76% below its 52-week high of 1,745.56, set on Oct 11, 2016.
52-week range
1,259.32Dec 14 20151,745.56Oct 11 2016
Markit short selling activity
Previous close1,630.50
Average volume11.24m
Shares outstanding4.88bn
Free float4.83bn
P/E (TTM)3,092.03
Market cap79.45bn GBP
EPS (TTM)0.0053 GBP
Annual div (IAD)80.00 GBX
Annual div yield (IAD)4.91%
Div ex-dateAug 11 2016
Div pay-dateOct 13 2016
Next div ex-dateNov 03 2016
Next div pay-dateJan 12 2017
Data delayed at least 20 minutes, as of Oct 28 2016 17:12 BST.
More ▼

Investors Chronicle View

The last IC recommendation on GlaxoSmithKline PLC shares was Hold at 1,637.00 on 22 Sep 2016Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.